MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
MetaVia Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.23−0.03 (-2.38%)
Close on Oct 19, 2026
- Market cap
- $7.30M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Dec 31, 2025 | 1-for-11 reverse | Earlier per-share figures multiplied by 11 |
| Dec 5, 2025 | 1-for-11 reverse | Earlier per-share figures multiplied by 11 |
| Mar 28, 2024(first seen in filings) | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Dec 21, 2023 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Nov 14, 2022(first seen in filings) | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Sep 13, 2022 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Mar 30, 2020(first seen in filings) | 1-for-2.75 reverse | Earlier per-share figures multiplied by 2.75 |
| Dec 31, 2019 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |